Streetbeat News

Stock Prices

BSET

EGLE

S

Insider purchases at Eagle Bulk Shipping, SentinelOne, and Bassett Furniture Industries signal confidence in these companies. Eagle Bulk Shipping's merger with Star Bulk was approved, SentinelOne received a positive analyst rating, and Bassett Furniture reported downbeat quarterly sales.

Portfolio Pulse from Avi Kapoor

April 08, 2024 | 12:41 pm

CAUD

Collective Audience (CAUD) shares are trading higher following the announcement of its acquisition of DSL Digital. This acquisition will enable Collective Audience to launch AI-powered AudienceServices, expanding its capabilities and offerings in the digital services sector.

Portfolio Pulse from Benzinga Newsdesk

April 08, 2024 | 12:41 pm

BTCUSD

XRPUSD

Ripple CEO Brad Garlinghouse predicts the cryptocurrency market cap could reach $5 trillion by 2024, driven by the launch of U.S. spot Bitcoin ETFs and the upcoming Bitcoin halving event. These developments, along with increased institutional investment, are expected to significantly impact the market dynamics. The first U.S. spot Bitcoin ETFs were approved on Jan. 10, and the Bitcoin halving event is set to occur later this month.

Portfolio Pulse from Murtuza Merchant

April 08, 2024 | 12:40 pm

JAGX

Jaguar Health, Inc. has been granted an extension until August 13, 2024, by Nasdaq to meet the $1.00 bid price requirement for continued listing. The company is also awaiting top line results from its Phase 3 OnTarget trial of crofelemer for the preventative treatment of cancer therapy-related diarrhea.

Portfolio Pulse from Benzinga Newsdesk

April 08, 2024 | 12:40 pm

TPCS

TechPrecision Corporation (NASDAQ:TPCS) announced the termination of its agreement to acquire Votaw Precision Technologies from Doerfer Corporation, initially set on November 22, 2023. The termination occurred on April 2, 2024, after both parties failed to agree on terms for reinstatement and extension of the agreement. As a result, Doerfer expects TechPrecision to issue 320,000 shares to them as a termination fee. TechPrecision is currently reviewing the situation.

Portfolio Pulse from Benzinga Newsdesk

April 08, 2024 | 12:39 pm

CAUD

Collective Audience, Inc. (NASDAQ:CAUD) is set to acquire DSL Digital, a Marketing-as-a-Service provider with proprietary AI technology, aiming to launch a new AudienceServices group. This acquisition will add a global customer base, an international services team, and AI-powered AdTech tools to Collective Audience's offerings. The deal, expected to close by the end of the current quarter, will be an all-stock transaction and is anticipated to generate significant revenue and positive EBITDA for Collective Audience.

Portfolio Pulse from Benzinga Newsdesk

April 08, 2024 | 12:38 pm

AMZN

GOOG

GOOGL

PFE

On CNBC's 'Halftime Report Final Trades,' analysts highlighted Amazon's construction restart in Bellevue, Alphabet's top rank in 'America's Most Innovative Companies 2024,' and Pfizer's 6.3% dividend yield. Amazon's shares rose 2.8%, Alphabet's 1.3%, and Pfizer's 0.04%.

Portfolio Pulse from Avi Kapoor

April 08, 2024 | 12:36 pm

AUUD

Auddia Inc.'s shares surged following the announcement that the USPTO awarded the company U.S. Patent 11,935,520 for its core AI technology used in the faidr app, which offers ad-free AM/FM radio stations to paid subscribers.

Portfolio Pulse from Benzinga Newsdesk

April 08, 2024 | 12:36 pm

XIACF

Xiaomi Corporation's (OTC:XIACF) launch of its first electric vehicle (EV), the SU7, in China has sparked a price war in the EV sector, leading to reduced profit margins for several companies. The SU7's competitive pricing has forced smaller EV manufacturers like Zeekr, Nio, and Aito to cut prices on their vehicles. Xiaomi's aggressive entry into the market has been marked by significant consumer interest, with over 50,000 orders received in less than half an hour.

Portfolio Pulse from Anan Ashraf

April 08, 2024 | 12:35 pm

CHRS

Coherus BioSciences, Inc. (NASDAQ:CHRS) presented preclinical data for CHS-1000, a novel anti-ILT4 antibody, at the 2024 AACR Annual Meeting. CHS-1000 shows high affinity for ILT4, reverses its immunosuppressive functions, and activates immune cells, suggesting potential to enhance antitumor responses with immunotherapy. CHS-1000 is the first immuno-oncology product developed by Coherus, with an IND submission planned for Q2 2024.

Portfolio Pulse from Benzinga Newsdesk

April 08, 2024 | 12:34 pm